A tale of two antiviral targets — and the COVID-19 drugs that bind them
Megan Cully
Topics & Concepts
Coronavirus disease 2019 (COVID-19)WaiverFormularyAuthorizationMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug developmentVirologyPolitical sciencePharmacologyDrugLawComputer scienceComputer securityInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfluenza Virus Research Studies